Biogen Inc. logo

Biogen Inc. (BIIB)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
205. 99
-2.93
-1.4024%
$
28.34B Market Cap
24.69 P/E Ratio
- Div Yield
1.15M Volume
14.99 Eps
$ 208.92
Previous Close
Add Transaction
Day Range
203.4 215.79
Year Range
121.05 219.72
Want to track BIIB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Biogen Inc. (BIIB) Statistics

Valuation metrics

Market Cap 28.34B
Enterprise value 33.59B
Trailing P/E (ttm) 21.98
Forward P/E 11.63
PEG ratio -2.83
Price/Sales (ttm) 3.09
Price/Book (mrq) 1.63
Enterprise Value/Revenue 3.41
Enterprise Value/EBITDA 12.43

Overview

Shares outstanding 147.6M
Float 147.18M
Shares short 4.48M
% Held by insiders 0%
% Held by institutions 0.96%
Average volume (10 days) 2M
Average volume (90 days) 1.26M

Price summary

52-Week low 121.05
52-Week high 219.72
Beta 0.2
50-Day moving average 200.96
200-Day moving average 187.57

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Feb 2017
Ex-Dividend Date 2 Feb 2017
Last split factor 3:1
Last split Date 18 Jan 2001

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.14%
Operating margin 0.16%

Operational effectiveness

Return on assets 0.05%
Return on equity 0.08%

Income Statement

Revenue (ttm) 9.94B
Revenue per share (ttm) 66.97
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 7.82B
EBITDA 3.27B
Net income to common (ttm) 1.37B
Diluted EPS (ttm) 9.32
Quarterly earnings growth (yoy) 0.33%

Balance Sheet

Total cash (mrq) 4.28B
Total cash per share (mrq) 29.09
Total debt (mrq) 6.56B
Total Debt/Equity (mrq) 0.35
Current ratio (mrq) 3.06%
Book value per share (mrq) 126.71

Cash Flow

Cash flow statement 2.59B
Levered free cash flow (LFCF) 1.92B